- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
IOL Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 1973.0
- ISIN : INE485C01029
-
Today’s Low
61.50 -
Today’s High
64.21

-
Open
61.75 -
Perv Close
61.15 -
52W Low
58.65 -
52W High
107.54
Key Indicators
-
P/E(TTM)
19.19
-
Mar.Cap (₹Cr.)
1,871.24
-
Div & Yield %
1.57
-
Book Value(₹)
56.51
-
Debt-Equity Ratio
4.25
-
AGM Date
01-Apr-2025
-
EPS
3.32
-
P/E Ratio
19.19
Financials Ratios
-
Debt-Equity Ratio
0.04
-
Mar.Cap (₹Cr.)
1,871.24
-
RONW (%)
8.62
-
ROCE (%)
12.21
Score Board
-
Equity (₹ in Cr.)
58.71
-
BV (₹)
56.50
-
Sales( ₹ in Cr.)
2,132.79
-
NP (in Cr.)
135.35
-
NP Var(%)
-3.0
-
Div%
50.0
-
CPS (₹)
6.80
-
EPS (₹)
4.60
-
Traded Value (₹ in Lakhs)
1,870.36
-
52 Week High
107.54
-
52 Week Low
58.65
-
Price BSE
64.0
-
Price NSE
64.00
-
Market Capital( in Cr.)
1,870.36
-
P/C Ratio
9.50
-
P/E Ratio
13.90
-
Price Vs.BV
4.60
-
06-Mar-2025( 10:27)
Hot Pursuit - IOL C... - The said certification will en...
-
13-Feb-2025( 11:10)
Market Beat - IOL C... - IOL Chemicals & Pharmaceutical...
-
13-Feb-2025( 09:31)
Corporate News - Board... - IOL Chemicals & Pharmaceutical...
-
13-Feb-2025( 07:41)
Results - Announcements - IOL C... - Net profit of IOL Chemicals &...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|---|
Sales Turnover | 2,132.79 | 2,217.11 | 2,184.02 | 1,966.98 | 1,894.47 | 1,685.33 |
Excise Duty | 2,118.96 | 2,201.69 | 2,168.37 | 1,946.14 | 1,863.51 | 1,655.02 |
Net Sales | 2,132.79 | 2,217.11 | 2,184.02 | 1,966.98 | 1,894.47 | 1,685.33 |
Other Income | 30.07 | 25.57 | 32.04 | 24.30 | 16.02 | 10.37 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 2,162.86 | 2,242.68 | 2,216.06 | 1,991.28 | 1,910.49 | 1,695.70 |
EXPENDITURE : | ||||||
Raw Materials | 2,118.96 | 2,201.69 | 2,168.37 | 1,946.14 | 1,863.51 | 1,655.02 |
Power & Fuel Cost | 2,118.96 | 2,201.69 | 2,168.37 | 1,946.14 | 1,863.51 | 1,655.02 |
Employee Cost | 201.02 | 168.21 | 141.30 | 115.55 | 97.20 | 78.43 |
Other Manufacturing Expenses | 46.34 | 31.87 | 28.93 | 21.90 | 13.58 | 20.50 |
Selling & Administrative Expenses | 60.24 | 68.37 | 71.96 | 55.26 | 51.31 | 39.88 |
Miscellaneous Expenses | 46.34 | 31.87 | 28.93 | 21.90 | 13.58 | 20.50 |
Less : Pre-operative Expenses Capitalised : | ||||||
Total Expenditure | 1,980.22 | 2,053.19 | 1,979.29 | 1,419.89 | 1,377.25 | 1,359.55 |
Operating Profit | 196.72 | 175.05 | 115.04 | 79.59 | 93.49 | 89.62 |
Interest | 16.10 | 16.47 | 8.29 | 5.83 | 20.93 | 51.42 |
Gross Profit | 182.64 | 189.49 | 222.84 | 571.39 | 533.24 | 336.15 |
Depreciation | 62.85 | 46.13 | 43.26 | 38.92 | 35.73 | 32.45 |
Profit Before Tax | 182.64 | 189.49 | 222.84 | 571.39 | 533.24 | 336.15 |
Tax | 37.01 | 46.26 | 57.01 | 145.55 | 172.90 | 71.96 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 10.21 | 3.25 | 0.17 | -18.72 | 1.05 | 70.07 |
Reported Net Profit | 135.42 | 139.98 | 165.66 | 444.56 | 361.29 | 236.70 |
Extraordinary Items | 182.64 | 189.49 | 222.84 | 571.39 | 533.24 | 336.15 |
Adjusted Net Profit | 135.42 | 139.98 | 165.66 | 444.56 | 361.29 | 236.70 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Statutory Appropriations | 29.35 | 23.48 | 23.48 | 35.22 | 17.07 | 0.00 |
P & L Balance carried down | 135.42 | 139.98 | 165.66 | 444.56 | 361.29 | 236.70 |
Dividend | - | - | - | - | - | - |
Preference Dividend | - | - | - | - | - | - |
Equity Dividend (%) | 50.00 | 40.00 | 40.00 | 60.00 | 30.00 | 0.00 |
Dividend Per Share(Rs) | 5.00 | 4.00 | 4.00 | 6.00 | 3.00 | 0.00 |
Earnings Per Share-Unit Curr | 23.07 | 23.84 | 28.22 | 76.21 | 63.51 | 42.11 |
Book Value | 29.35 | 23.48 | 23.48 | 35.22 | 17.07 | 0.00 |
Book Value(Adj)-Unit Curr | 29.35 | 23.48 | 23.48 | 35.22 | 17.07 | 0.00 |
Company Background
IOL Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln
- IOL Chemicals & Pharmaceuticals Ltd
- BSE Code : 1973.0
- ISIN : INE485C01029
-
Incorporation Year
1986
-
Registered Office
Trident Complex
Raikot Road Barnala, Sangrur,
Punjab-148101 -
Telephone
91-01679-244701-07
-
FAX
91-01679-244708
-
Chairman
Rajender Mohan Malla
-
Managing Director
Varinder Gupta
-
Company Secretary
Abhay Raj Singh
-
Auditor
Ashwani & Associates
-
Face Value
2
-
Listing
NSE
-
Registrar
Alankit Assignments Ltd
Alankit Heights ,
1E/13 Jhandewalan Ex,
Mumbai - New Delhi-110055
IOL Chemicals & Pharmaceuticals Ltd Peer Comparison
Select | Company Name | LTP (₹) | Revenue | Sales | P/E Ratio | ROCE % |
---|---|---|---|---|---|---|
IOL Chemicals | 63.72 | 2,162.86 | 2,132.79 | 19.19 | 12.27 | |
Abbott India | 30,305.85 | 6,097.18 | 5,848.91 | 48.26 | 44.71 | |
Astrazeneca Phar | 8,518.55 | 1,330.33 | 1,295.53 | 219.61 | 33.26 | |
P & G Health Ltd | 5,152.30 | 1,166.89 | 1,151.26 | 36.15 | 39.76 | |
Glaxosmi. Pharma | 2,793.40 | 3,530.73 | 3,407.25 | 55.55 | 44.44 | |
Cipla | 1,444.55 | 17,645.00 | 16,574.34 | 24.77 | 20.10 | |
Amrutanjan Healt | 642.85 | 437.58 | 421.23 | 37.68 | 20.84 | |
Fermenta Biotec. | 285.30 | 315.24 | 307.09 | 27.04 | 4.10 | |
Guj. Themis Bio. | 271.85 | 174.19 | 169.82 | 56.28 | 44.82 | |
Bliss GVS Pharma | 119.25 | 638.96 | 605.46 | 27.29 | 11.19 | |
Ambalal Sarabhai | 36.15 | 11.70 | 3.81 | 15.45 | 1.92 |